Jpmorgan Chase & CO Dr Reddys Laboratories LTD Call Options Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RDY
# of Institutions
262Shares Held
92.5MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.12.2MShares$169 Million0.3% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$139 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$125 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$88.4 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$75.1 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...